Polyoma middle T-induced vascular tumor formation: The role of the plasminogen activator/plasmin system

Journal of Cell Biology

Volumn 137, Issue 4, 1997, Pages 953-963

  Sabapathy, Kanaga T ^a   Pepper, Michael S ^c   Kiefer, Friedemann ^b   Möhle Steinlein, Uta ^a   Tacchini Cottier, Fabienne ^c   Fetka, Ingrid ^a   Breier, Georg ^d   Risau, Werner ^d   Carmeliet, Peter ^e   Montesano, Roberto ^c   Wagner, Erwin F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^e DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PLASMIN; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VIRUS MIDDLE T ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; MALE; MORPHOGENESIS; NEWBORN; NONHUMAN; NUDE MOUSE; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; VASCULAR TUMOR;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CELL TRANSFORMATION, VIRAL; ENDOTHELIUM, VASCULAR; FIBRIN; GELS; GENE EXPRESSION; MICE; MICE, KNOCKOUT; MORPHOGENESIS; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RNA, MESSENGER; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR; VASCULAR NEOPLASMS;

EID: 14444278730     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.137.4.953     Document Type: Article

References (23)

1. Brizuela, L., L.M. Olcese, and S.A. Courtneidge. 1994. Transformation by middle T antigens. Semin. Virol. 5:381-389.
2. Bugge, T.H., M.J. Flick, C.C. Daugherty, and J.L. Degan. 1995a. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes & Dev. 9:794-807.
3. Bugge, T.H., T.T. Suh, M.J. Flick, C.C. Daugherty, J. Rømer, H. Solberg, V. Ellis, K. Danø, and J.L. Degan. 1995b. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J. Biol. Chem. 270:16886-16894.
4. Bugge, T.H., M.J. Flick, M.J.S. Danton, C.C. Daugherty, J. Rømer, K. Danø, P. Carmeliet, D. Collen, and J.L. Degan. 1996. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA. 93:5899-5904.
5. Carmeliet, P., L. Kieckens, L. Schoonjans, B. Ream, A. Van Nuffelen, G. Prendergast, M. Cole, R. Bronson, D. Collen, and R.C. Mulligan. 1993a. Plasminogen activator inhibitor-1 gene-deficient mice 1. Generation by homologous recombination and characterization. J. Clin. Invest. 92:2746-2755.
6. Carmeliet, P., J.M. Stassen, L. Schoonjans, B. Ream, J.J. van den Oord, M. De Mol, R.C. Mulligan, and D. Collen. 1993b. Plasminogen activator inhibitor-1 gene-deficient mice 2. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92:2756-2760.
7. Carmeliet, P., L. Schoonjans, L. Kleckens, B. Ream, J. Degan, R. Bronson, R. de Vos, J.J. van den Oord, D. Collen, and R.C. Mulligan. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature (Lond). 368:419-424.
8. Danø, K., P.A. Andreasen, J. Grøndahl-Hansen, P. Kristensen, L.S. Nielsen, and L. Skriver. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266.
9. Dubois-Stringfellow, N., L. Kolpack-Martindale, V.L. Bautch, and R.G. Azizkhan. 1994a. Mice with hemangiomas induced by transgenic endothelial cells. A model for the Kasabach-Merritt syndrome. Am. J. Pathol. 144:796-806.
10. Dubois-Stringfellow, N., J. Jonczyk, and V.L. Baulch. 1994b. Perturbations in the fibrinolytic pathway abolish cyst formation but not capillary-like organization of cultured murine endothelial cells. Blood. 83:3206-3217.
11. Kiefer, F., S.A. Courtneidge, and E.F. Wagner. 1994a. Oncogenic properties of the middle T antigens of polyomavirus. Adv. Cancer Res. 64:125-157.
12. Kiefer, F., I. Anhauser, P. Soriano, A. Aguzzi, S.A. Courtneidge, and E.F. Wagner. 1994b. Endothelial cell transformation by the polyomavirus middle T antigen in mice lacking Src-related kinases. Curr. Biol. 4:100-109.
13. Lendrum, A.C., D.S. Fraser, W. Slidders, and R. Menderson. 1962. Studies on the character and staining of fibrin. J. Clin. Pathol. (Lond.). 15:401-413.
14. Montesano, R., M.S. Pepper, U. Möhle-Steinlein, W. Risau, E.F. Wagner, and L. Orci. 1990. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing middle T oncogene. Cell. 62:435-445.
15. Pepper, M.S., and R. Montesano. 1990. Proteolytic balance and capillary morphogenesis. Cell Differ. Dev. 32:319-328.
16. Pepper, M.S., R. Montesano, S. Mandriota, L. Orci, and J.-D. Vassalli. 1996. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein. 49:138-162.
17. Pepper, M.S., F. Tacchini-Cottier, T.K. Sabapathy, R. Montesano, and E. Wagner. 1997. Endothelial cells transformed by polyoma virus middle T oncogene: a model for hemangiomas and other vascular tumors. In Tumour Angiogenesis. R. Bicknell, C.E. Lewis, and N. Ferrara, editors. Oxford University Press. In press.
18. Ploplis, V.A., P. Carmeliet, S. Vazirzadeh, I. Van Vlaenderen, L. Moons, E.F. Plow, and D. Collen. 1995. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation. 92:2585-2593.
19. Taraboletti, G., A. Garofalo, D. Belotti, T. Drudis, P. Borsotti, E. Scanziani, P.D. Brown, and R. Giavazzi. 1995. Inhibition of angiogenesis and murine hemangioma growth by Batimastat, a synthetic inhibitor of matrix metallo-proteinases. J. Natl. Cancer Inst. 87:293-298.
20. Vassalli, J.-D., J.M. Dayer, A. Wohlwend, and D. Belin. 1984. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Med. 159:1653-1668.
21. Vassalli, J.-D., A.-P. Sappino, and D. Belin. 1991. The plasminogen activator/ plasmin system. J. Clin. Invest. 88:1067-1072.
22. Wagner, E.F., and W. Risau. 1994. Oncogenes in the study of endothelial cell growth and differentiation. Semin. Cancer Biol. 5:137-145.
23. Williams, R.L., S.A. Courtneidge, and E.F. Wagner. 1988. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell. 52:121-131.